Vor Biopharma


Robert Ang, M.D., President and CEO

April 10 | 3:30pm | Salone dei Cavalieri, Section 2

Cambridge, MA


Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant.


By using this website you agree to accept our Privacy Policy and Terms & Conditions